NFKB1 and acute myeloid leukemia: Inhibiting the abnormal expression of NF‐κB during AML progression and downregulating antiapoptotic pathways to restore normal apoptosis could potentially impede the proliferation and differentiation of LSCs, leading to a reduction in their number.213